Rare diseases
Investigational molecules
Locations
55 Tw Alexander Drive, 27709-0152, United States
United Therapeutics Corp. supports clinical research in fibrotic lung disease, with particular attention to idiopathic pulmonary fibrosis and related interstitial lung disease presentations. Its studies focus on inhaled therapies used in chronic pulmonary fibrosis settings and on outcomes relevant to lung function and disease progression.
The sponsor’s trial portfolio includes multinational research across multiple sites in North America, Europe, and other active regions.
United Therapeutics Corp. runs clinical trials in conditions such as Pulmonary hypertension, Interstitial lung disease, Pulmonary fibrosis, Idiopathic pulmonary fibrosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgiumBelgium
AustriaAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
